Cytosorbents Corp.

CTSO XNAS SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Market Cap

30M

Short interest (May 15)

3.3%

Net Short (Jun 03 ): -0.1%

Borrow Fee

0.64%

↑ 6.7%

Available Shares

700K

↓ 11.6%

Price Chart

Company Overview

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Company Info

Exchange: NASDAQ
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CIK: 0001175151
Asset Type: CS

Market Data

Market Cap: $30,141,479
Employees: 129
Status: Active

Short Interest

Current Borrow Fee 0.64%
Range: 0.61% - 0.66%
Available Shares 700K
Range: 650K - 1.2M

Recent Changes

Fee Change: ↑ 5.9%
Available Change: ↓ 20.8%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime